Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma. (Q48121628)
Jump to navigation
Jump to search
scientific article published on 23 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma. |
scientific article published on 23 December 2016 |
Statements
Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma (English)
Caifeng Deng
Quan Zhang